Nitric oxide: A regulator of mucosal defense and injury

Journal of Gastroenterology

Volumn 33, Issue 6, 1998, Pages 792-803

  Elliott, Susan N ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammation; Inflammatory bowel disease; Mucosal defense; Nitric oxide; Ulcer

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

CELL ACTIVATION; DIGESTIVE SYSTEM INFLAMMATION; GASTROINTESTINAL MUCOSA; HOST RESISTANCE; HUMAN; INTESTINE EPITHELIUM; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; STOMACH ULCER; TISSUE INJURY; ULCER HEALING;

ANIMALS; DUODENAL ULCER; FREE RADICAL SCAVENGERS; GASTRIC MUCOSA; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; NEUTROPHIL ACTIVATION; NEUTROPHILS; NITRIC OXIDE; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; STOMACH ULCER;

EID: 0032457409     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050178     Document Type: Review

References (103)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
2. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298:249-258.
3. Griffith OW, Stuehr DJ. Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev Physiol 1995;57:707-736.
4. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996;270:G225-G237.
5. Kubes P, Wallace JL. Nitric oxide as a mediator of gastrointestinal mucosal injury? Say it ain't so. Mediators Inflamm 1995;4:397-405.
6. MacNaughton W, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869-1876.
7. Masuda E, Kawano S, Nagano K, et al. Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats. Gastroenterology 1995;108:58-64.
8. Bjarnason I, O'Morain C, Levi AJ, Peters T. Absorption of 51 chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-322.
9. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: A novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-1626.
10. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992;262:G1138-G1142.
11. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, et al. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993;264:11-16.
12. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial cell permeability via mast cells. Am J Physiol 1994;266:G222-G229.
13. Coskun T, Yegen B, Alican I, et al. Cold restraint stress-induced gastric mucosal dystunction. Role of nitric oxide. Dig Dis Sci 1996;41:956-963.
14. Boughton-Smith N, Evans S, Laszlo F, et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993;110:1189-1193.
15. Brown J, Keates A, Hanson P, Whittle B. Nitric oxide generators and cGMP stimulate mucus secretion by gastric mucosal cells. Am J Physiol 1993;265:G418-G422.
16. Brown J, Hanson P, Whittle B. Nitric oxide donors increase mucus gel thickness in rat stomach. Eur J Pharmacol 1992; 223:103-104.
17. Gottke M, Chadee K. Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells. Inflamm Res 1996;45:209-212.
18. Price K, Hanson P, Whittle B. Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide. Eur J Pharmacol 1994;263:199-202.
19. MacNaughton WK. Nitric oxide-donating compounds stimulate electrolyte transport in the guinea pig intestine in vitro. Life Sci 1993;53:585-593.
20. Wilson KT, Xie Y, Musch MW, Chang EB. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon. J Pharmacol Exp Ther 1993;266:224-230.
21. Stack WA, filipowicz B, Hawkey CJ. Nitric oxide donating compounds stimulate human colonic ion transport in vitro. Gut 1996;39:93-99.
22. 2 in nitroprusside-stimulated rat colonic ion transport. Am J Physiol 1996;270:C832-C840.
23. Salvemini D, Misko T, Masferrer J, et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90: 7240-7244.
24. Mascolo N, Izzo AA, Barbato F, Capasso F. Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat. Br J Pharmacol 1993;108:861-864.
25. Schirgi-Degen A, Beubler E. Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo. Br J Pharmacol 1995;114:13-18.
26. Salvemini D, Masini E, Pistelli A, et al. Nitric oxide: A regulatory mediator of mast cell reactivity. J Cardio Pharmacol 1991;17:S258-S264.
27. Hogaboam C, Befus D, Wallace JL. Modulation of rat mast cell reactivity by IL-1β. Divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993;151:3767-3774.
28. Masini E, Salvemini D, Pistelli A, et al. Rat mast cells synthesize a nitric oxide-like factor which modulates the release of histamine. Agents Actions 1991;33:61-63.
29. Kubes P, Kanwar S, Niu X, Gaboury J, Nitric oxide synthesis inhibition induced leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293-1299.
30. Kubes P, Arfors KE, Granger DN. Platelet-activating factor-induced mucosal dysfunction: Role of oxidants and granulocytes. Am J Physiol 1991;260:G965-G971.
31. Miller MJS, Zhang X, Barkemeyer B, et al. Potential role of histamine monochloramine in a rabbit model of ileitis. Scand J Gastroenterol 1991;26:852-858.
32. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defense. FASEB J 1996;10:731-740.
33. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24:739-768.
34. Lippe IT, Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol 1992;105:708-714.
35. Holzer P, Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neutrons. Gastroenterology 1986;91:975-981.
36. Kitagawa H, Takeda F, Kohei H. Effect of endothelium-derived relaxing factor on the gastric lesion induced by HCI in rats. J Pharmacol Exp Ther 1990;253:1133-1137.
37. Ferraz JGP, McKnight W, Sharkey KA, Wallace JL. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. Gastroenterology 1995;108:1183-1191.
38. Wallace JL, Cirino G, De Nucci G, et al. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol 1989;256:G661-G666.
39. Wallace JL, Keenan CM, MacNaughton WK, McKnight GW. Comparison of the effects of endothelin-1 and endothelin-3 on the rat stomach. Eur J Pharmacol 1989;167:41-47.
40. Lopez-Belmonte J, Whittle B, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993;108:73-78.
41. DeNucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
42. Fllep J, Foldes-Filep E, Rousseau A, et al. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 1993;110:1213-1221.
43. MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993;34:222-228.
44. Hutcheson I, Whittle B, Boughton-Smith N. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990;101:815-820.
45. Andrews F, Malcontenti-Wilson C, O'Brien P. Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig Dis Sci 1994;39:366-373.
46. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
47. Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol 1990;259:G859-G864.
48. Kurose I, Kubes P, Wolf R, et al. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 1993;73:164-171.
49. Wallace JL, Reuter B, Cicala C, et al. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994;107: 173-179.
50. Wallace JL, Cirino G, McKnight GW, Elliott SN. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol 1995;280:63-68.
51. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils. Am J Physiol 1997;273:G1246-G1251.
52. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991;289:130-136.
53. Rubanyi GM, Ho EH, Cantor EH, et al. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991;181: 1392-1397.
54. Gaboury J, Woodman R, Granger DN, et al. Nitric oxide prevents leukocyte adherence: Role of superoxide. Am J Physiol 1993;265:H862-H867.
55. Perry MA, Wadhwa S, Parks DA, et al. Role of oxygen radicals in ischemia-induced lesions in the cat stomach. Gastroenterology 1986;90:362-367.
56. Zimmerman BJ, Grisham MB, Granger DN. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 1990;258:G185-G190.
57. Clancy R, Leszczynska-Piziak J, Abramson S. Nitric oxide, and endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992;90:1116-1121.
58. Konturek SJ, Brzowzowski T, Majka J, et al. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993;239:215-217.
59. Elliott SN, McKnight W, Cirino G, Wallace JL. A nitric-oxide releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995;109:524-530.
60. Gorfine SR. Topical nitroglycerin therapy for anal fissures and ulcers. N Engl J Med 1995;333:1156-1157.
61. Laszlo F, Whittle B, Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 1994;111: 1309-1315.
62. Miller MJS, Thompson J, Liu X, et al. Failure of L-NAME to cause inhibition of nitric oxide synthesis: Role of inducible nitric oxide synthase. Inflamm Res 1996;45:272-276.
63. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-3243.
64. Rachmilewitz D, Karmeli F, Eliakim R, et al. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut 1994;35:1394-1397.
65. Aiko S, Grisham MB. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 1995;109:142-150.
66. Ribbons K, Zhang X, Thompson J, et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 1995;108:705-711.
67. Hogaboam C, Jacobson K, Collins S, Blennerhassett M. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995;268:G673-G684.
68. Miller MJS, Clark D. Nitric oxide synthase inhibition can initiate or prevent gut inflammation: Role of enzyme source. Agents Actions 1994;41:C231-C232.
69. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995;37:247-255.
70. Rachmilewitz D, Stamler J, Karmeli F, et al. Role of nitric oxide in the pathogenesis of IBD. In: Monteiro E, Tavarela Veloso F, eds. Inflammatory bowel disease. New insights into mechanisms of inflammation and challenges in diagnosis and treatment. Lancaster: Kluwer Academic 1995;53-60.
71. Rajora N, Boccoli G, Catania A, Lipton J. α MSH modulates experimental inflammatory bowel disease. Peptides 1997;18:381-385.
72. Grisham MB, Specian R, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharm Exp Ther 1994;271: 1114-1121.
73. Laszlo F, Whittle B. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon. Eur J Pharmacol 1997;34:99-102.
74. Unno N, Wang H, Menconi M, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113: 1246-1257.
75. Szabo C, Southan G, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12 472-12 476.
76. Miller MJS, Thompson J, Zhang X, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475-1483.
77. Misko T, Moore W, Kasten T, et al. Selective inhibition of the inducible nitric oxide sythase by aminoguanidine. Eur J Pharmacol 1993;233:119-125.
78. Tepperman B, Brown J, Whittle B. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993;265:G214-G218.
79. Roediger W, Lawson M, Nance S, Radcliffe B. Detectable colonic nitrite levels in inflammatory bowel disease - mucosal or bacterial malfunction? Digestion 1986;35:199-204.
80. Lundberg J, Hellstrom P, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-1674.
81. Middleton S, Shorthouse M, Hunter J. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341:465-466.
82. Rachmilewitz D, Stamler J, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-723.
83. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995;109:1497-1502.
84. Kolios G, Brown Z, Robson R, et al. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 1995;116:2866-2872.
85. Boughton-Smith N, Evans S, Hawkey C, et al. Differential changes in nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993;342:338-340.
86. McLaughlan J, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997;181:87-92.
87. Palmer RMJ, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1992;105:11-12.
88. Beckman J, Koppenol W. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 1996;271:C1424-C1437.
89. Mariotto S, Cuzzolin L, Adami A, et al. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 1995;114:1105-1106.
90. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
91. Miller MJS, Grisham MB. Nitric oxide as a mediator of inflammation? You had better believe it. Mediators Inflamm 1995;4: 387-396.
92. Rachmilewitz D, Stamler J, Karmeli F, et al. Peroxynitrite-induced rat colitis. A new model of colonic inflammation. Gastroenterology 1993;105:1681-1688.
93. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-350.
94. Karupiah G, Xie Q, Buller R, et al. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science 1993;261:1445-1448.
95. MacMicking J, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-650.
96. Hartley M, Hudson M, Swarbrick E, et al. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 1992;36:96-103.
97. Tepperman B, Soper B, Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol 1994;72:1308-1312.
98. McCafferty D, Mudgett J, Swain M, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997;112:1022-1027.
99. Peng H, Libby P, Liao J. Induction and stabilization of IKB-alpha by nitric oxide mediates inhibition of NF-κB. J Biol Chem 1995;270:14214-14219.
100. Kubes P, Shihota E, Hickey M. Endogenous but not exogenous nitric oxide decreases TNF-α-induced leukocyte rolling. Am J Physiol 1997;273:G628-G635.
101. Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ishcemia-reperfusion injury in rats. J Clin Invest 1997;99:684-691.
102. Miles A, Bohle D, Glassbrennor P, et al. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996;271:40-47.
103. Kubes P, Reinhardt P, Payne D, Woodman R. Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine. Am J Physiol 1995;269:G34-G41.